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 Protective transgender-specific policies (including those related to experiences of 
discrimination, health insurance coverage, and changing legal documents) are associated 
with increased access to medical gender affirmation services (hormone treatment, 
therapy/counseling) for transgender and other gender-diverse people. Restrictive 
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 The relationship between race/ethnicity and use of medical gender affirmation services 
varies across states and is context specific, indicating that race/ethnicity also plays a role in 
access to these types of care across states.  
 Advocacy is needed to prevent or overturn restrictive policies and promote protective 
policies for transgender and other gender-diverse people, especially for people of color. 
 
Context: In the 2010s, the number of federal, state, and local transgender-specific policies increased. 
Some of these policies advanced protections for transgender and other gender-diverse (TGGD) 
people, and others were restrictive. Little is known about the relationships between these policies 
and use of medical gender affirmation services (eg, hormone treatment, therapy/counseling), or 
about how these associations may vary among different racial and ethnic groups. 
 
Methods: Multilevel modeling was used to examine the associations between state-level 
transgender-specific policies and the use of medical gender affirmation services among TGGD people 
in the United States. Data are from the 2015 U.S. Trans Survey of nearly 28,000 TGGD people. The 
medical gender affirmation services examined in this study were hormone treatment and 
therapy/counseling. The state policies we analyzed addressed discrimination, health insurance 
coverage, and changing legal documents; these policies were measured individually and as a 
composite index. Race/ethnicity was included in the multilevel regression models as a random slope 
to determine whether the relationship between race/ethnicity and the use of medical gender 
affirmation services varied by state. 
 
Findings: Individual policies and the policy index were associated with both outcomes (use of 
therapy/counseling and hormone treatment services), indicating that protective policies were 
associated with increased care. Broad religious exemption laws and Medicaid policies that excluded 
transgender-specific care were both associated with less use of therapy/counseling, whereas 
transgender-care-inclusive Medicaid policies were associated with more use of therapy/counseling. 
Nondiscrimination protections that include gender identity were associated with increased use of 
hormone treatment services. The relationship between race/ethnicity and medical gender 
affirmation services varied across states. 
 
Conclusions: State-level transgender-specific policies influence medical gender affirmation service 
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TGGD people of color differently. Advocacy is needed to repeal restrictive policies and promote 
protective policies in order to reduce health inequities among TGGD people, especially people of 
color. 
 
Keywords: Transgender, medical gender affirmation, hormone treatment, intersectionality, therapy, 
stigma, policies, health care. 
<PE-FRONTEND> 
 
Although not all transgender and other gender-diverse (TGGD) people (ie, individuals whose 
gender identity is not the same as the sex assigned to them at birth) seek medical gender affirmation 
services (eg, therapy/counseling, hormone treatment, surgery), these services play an essential role 
in improving quality of life and mental health for those who do.1 However, there are often numerous 
barriers to accessing these services,2-4 and many TGGD people are unable to access these services 
when they want them.5 Research exploring these barriers has focused on issues related to health 
insurance and the health care experience (eg, stigma within health care settings, medical 
gatekeeping, lack of provider knowledge),2,4 but little is known about how state-level US policies 
influence the use of medical gender affirmation services. 
The prevalence of state and federal policies specific to the experiences of TGGD people has 
been increasing over the past decade.6,7 These policies are both restrictive and protective, and are 
important for the health of TGGD people.8-10 Such policies can determine access to resources (eg, 
employment, housing, health insurance), and they can influence and/or reflect how accepting or 
stigmatizing a social environment is for TGGD people. Previous research demonstrates that living in 
environments with more protective policies, and fewer stigmatizing ones, is associated with 
improved mental and physical health outcomes and increased access to health care for TGGD 
people.8-10 For example, Du Bois and colleagues used data from the Behavioral Risk Factor 
Surveillance System (BRFSS) across 26 US states, and found that living in states with more protective 
TGGD-specific policies was associated with TGGD people having better mental health, reduced 
alcohol use, and a shorter time since the last routine health care checkup.8  
To our knowledge, the research exploring relationships between TGGD-related policies and 
health care use has not examined the role that state-level TGGD-specific policies play in access to 
medical gender affirmation services. Accessing medical gender affirmation services is   a unique 
health care experience, and more research is needed to understand its relationships to specific 
policies and the policy climate. 
Race and ethnicity may play a role in access to medical gender affirmation services, as they 
do in access to general health services. Using an intersectionality approach,11 we can consider how 
stigma related to multiple marginalized identities influences access to care. TGGD people of color 
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but their experiences of transgender-related stigma may be different than those of their non-
Hispanic white counterparts, with a greater prevalence and severity of stigma and increased 
consequences to stigma.5,12-15 TGGD people of color report experiencing higher rates of transgender-
related victimization and discrimination.5 Because of stigma, TGGD people of color also experience 
more systemic vulnerability (eg, homelessness, unemployment, incarceration), resulting in increased 
exposure to health risks.5 Racism and transgender-related stigma embedded within health care 
systems can also create challenges for accessing care,16,17 with people of color being more likely to 
receive worse treatment and have more mistrust in health care providers and medical systems.18,19 
These forms of stigma may create additional barriers for accessing medical gender affirmation 
services. To explore these issues, we assessed how the relationship between state-level TGGD-




Data are from the U.S. Trans Survey (USTS), a national survey of TGGD people, implemented 
by the National Center for Transgender Equality (NCTE).20 Additional details about recruitment, data 
collection procedures, the survey instrument, and data cleaning are included in the USTS study 
report.5 
 
Study Sample and Recruitment 
 
With the help of approximately 400 lesbian, gay, bisexual, transgender, and queer (LGBTQ) 
organizations, the NCTE used multiple strategies (eg, email, social media, promotional campaigns) to 
recruit 27,715 participants for the USTS. Eligibility criteria included identifying along a spectrum of 
TGGD identities, being at least age 18 years, and living in a US state or territory. For this analysis, we 
excluded responses from individuals who identify as crossdressers (n = 758) and those living in US 












USTS data were collected from August to September 2015. The survey was conducted online 
in English and Spanish, and approximately 200 participants completed it at in-person survey events 
at LGBTQ organizations. The survey covered a broad range of topics (eg, health, employment, 
housing). All data were collected anonymously, and participants entered a cash-prize drawing as an 
incentive. The NCTE attained approval from the University of California–Los Angeles North General 





Measures included medical gender affirmation outcomes, state-level TGGD-specific 
policies, and individual-level and state-level covariates.  
Medical Gender Affirmation Services. Two medical gender affirmation outcomes were 
included: therapy/counseling and hormone treatment. Although therapy/counseling could be used 
for reasons beyond medical gender affirmation, the USTS specifically asked about the use of 
therapy/counseling for “gender identity or gender transition.” For each outcome, the analysis only 
included individuals who reported ever wanting that type of health care (ie. therapy/counseling or 
hormone treatment), and the variables were measured based on whether these services were ever 
accessed. Although the USTS included data on medical gender affirmation surgeries, this analysis 
only examined the use of therapy/counseling and hormone treatment as outcomes because there 
were too few participants of color in each state who had accessed these surgeries for us to explore 
associations between race/ethnicity and surgical health care use outcomes across US states. 
Policies. State-level policy data were from the Movement Advancement Project, an 
independent nonprofit think tank whose mission is to “provide rigorous research, insight and 
communications that help speed equality and opportunity for all;” the organization’s research 
includes reports and maps addressing state-level policies specific to the experiences of LGBTQ 
people.21  Six types of policies that may influence access to medical gender affirmation services were 
analyzed: inclusion of gender identity/expression in nondiscrimination policies, religious exemption 
laws (ie. laws that enable people, churches, businesses, and other organizations and institutions to 
refuse to provide services to TGGD people based on their religious beliefs; for example, this can 
include refusal to offer adoption services, reproductive healthcare services, government services 
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policies, regulations for changing a gender marker on state-issued identification, and regulations for 
legally changing one’s name. These policies vary across states (Figures 1-3) and may influence access 
to medical gender affirmation services. 
State-level policies were determined based on the policies that existed at the start of the 
USTS data collection (August 2015). However, data were not publicly available for identity document 
policies in 2015, so  we used Movement Advance Project data from February 2017 for legal name 
changes and from July 2018 for changing a gender marker. 
We examined the six types of policies separately and in a cumulative index that captures the 
policy climate of each state. Analyzing the policies separately helped us understand how each policy 
is associated with therapy/counseling and hormone treatment, and using a policy index elucidated 
how the broader sociopolitical context was associated with medical gender affirmation service use. 
To create the index, we ranked each state in the six policy areas. For each policy, a state received a 
score of –1 if the policy was harmful, a +1 if the policy was protective, and a 0 if the policy did not 
exist. The index is a sum of the points across the six policy types. The final composite index ranged 
from –3 to 5 and the distribution of the index across states is presented in Figure 4. 
Individual-Level Covariates. Individual-level covariates in our study included 
demographics, experiences of stigma, outness, social support, systemic vulnerability, health status, 
and health insurance coverage. We selected these covariates because previous research 
demonstrated that these factors influence health care access.19,22  
Demographic variables included age, gender identity, sexual orientation, race/ethnicity, US 
citizenship status, highest education level, and employment status. The gender identity variable was 
comprised of four categories: transfeminine (ie, individuals assigned male at birth who identify as a 
woman, a trans woman, etc.), transmasculine (ie, individuals assigned female at birth who identify as 
a man, a trans man, etc.), and other gender diverse, with the latter category including separate 
categories for those assigned male at birth and those assigned female at birth. Sexual orientation 
was classified as heterosexual/straight, LGB+ (ie, lesbian, gay, bisexual, and other sexual identities 
such as queer, same-gender loving, and pansexual), asexual, or other. Race/ethnicity included non-
Hispanic white; American Indian or Alaska Native; Asian, Native Hawaiian, or Pacific Islander; black; 
Latinx/Hispanic; multiracial; or other race. Education included four categories: high school graduate, 
some college, undergraduate degree, and graduate/professional degree. Current employment status 
was categorized as being employed, unemployed, or out of the labor force. 
Transgender-related stigma and racism variables included single items to assess experiences 
of discrimination, verbal victimization, and physical violence occurring in the past year. These 
experiences were classified as transgender-related stigma if participants attributed these 
experiences to their transgender status/gender identity and/or gender expression/appearance. 
Experiences were classified as racism if participants attributed them to their race. 
Gender expression was measured based on whether participants were living full time in a 
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each point on the scale indicated a social group to whom the respondent had disclosed their gender 
identity, including family (immediate and extended), friends (LGBTQ and non-LGBTQ), colleagues (a 
boss/manager/supervisor and coworkers), classmates, and health care providers. A binary social 
support variable captured whether immediate family, coworkers, and/or classmates provide social 
support. 
Systemic vulnerability was examined through four separate binary variables measuring 
lifetime experiences of homelessness and sex work, current experiences of poverty, and 
incarceration in the past year. Health status included measures of health outcomes found to be 
disproportionately experienced by TGGD populations,5,23,24 including experiences of psychological 
distress in the past 30 days (measured through the Kessler Psychological Distress Scale),25 lifetime 
experiences of suicidal ideation, HIV status, having had at least one incident of binge drinking in the 
past 30 days, and any illicit drug use or prescription drugs use not as prescribed in the past 30 days. 
Health insurance was measured based on whether the participant had any type of health coverage. 
State-Level Control Variables. State-level control variables included each state’s racial 
makeup, population density, and urban makeup. These contextual factors may influence access to 
medical gender affirmation services. Data on racial makeup were from the U.S. Census Bureau’s 
2017 American Community Survey26 and included the percentage of the population that is non-
Hispanic white. Population-density data were from the 2010 decennial US Census and were 
measured as the number of people per square mile. The proportion of each state that was urban 
was determined using the 2013 U.S. Department of Agriculture Rural-Urban Continuum Codes.27 




We used STATA 14 to analyze data and ran multilevel logistic regressions to understand the 
relationships between state-level TGGD-specific policies and medical gender affirmation service use. 
Missing data on the outcome variable were missing at random, and none of the covariates were 
missing more than 10% of responses; therefore, all missing data were dropped from the data set, 
resulting in sample sizes of 18,195 participants who reported wanting therapy/counseling and 
18,421 participants who reported wanting hormone treatment. Multicollinearity was assessed, and 
the model was re-specified to ensure that none of the independent variables were too closely 
associated with each other. Descriptive statistics were computed, and bivariate analyses examined 
the independent relationships between each independent variable and each outcome using chi-
square tests and t tests. An alpha level of 0.05 was used to determine significance for all analyses.  
For each outcome (therapy/counseling and hormone treatment), two separate models were 
fit: one model included the composite policy score, and the other included all policies as separate 




This article is protected by copyright. All rights reserved. 
 
8 
random intercept; this included all 50 states and the District of Columbia. Race/ethnicity was 
included as the random slope. Because the sample size of TGGD people of color was small relative to 
the overall sample and there were too few TGGD people of color in each state to explore 
race/ethnicity in a more nuanced way, for the random slope, race/ethnicity was measured as a 
binary variable based on whether an individual was non-Hispanic white or a person of color. The 
random slope determines whether the relationship between race/ethnicity and medical gender 




Descriptive Statistics and Bivariate Analyses 
 
Descriptive statistics and results of bivariate analyses are presented in Tables 1 and 2. The majority 
of participants in our samples reported using therapy/counseling (67.33%, n = 12,250) and/or 
hormone treatment (61.38%, n = 11,307). The mean age of participants in both samples was 
approximately 31years (range 18 to 81 years). Approximately 40% of participants in our samples 
were transfeminine, and most participants were LGB+, non-Hispanic white, and US citizens. About 
two-thirds of participants were employed, and just over 85% had at least some college education. 
Generally, participants disproportionately lived in states with protective policies (eg, California and 
New York). 
 
Multilevel Logistic Regression 
 
Fully adjusted regression models demonstrated that the policy composite score was 
significantly associated with both therapy/counseling and hormone treatment use. For each 
additional point on the 9-point index, the odds of receiving therapy/counseling increased by 4% 
(95% confidence interval (CI) = 1.003-1.07 , P = .031; data not shown) and the odds of receiving 
hormone treatment increased by 6% (95% CI = 1.02-1.11, P = .003; data not shown).  
When examining the policies separately, we found that individual policies were associated 
with both therapy/counseling and hormone treatment use (Table 3). Living in a state with a broad 
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= 0.74-0.96, P = .010). Individuals living in states with TGGD exclusions in Medicaid policies were less 
likely to use therapy/counseling (adjusted odds ratio [aOR] and 95% CI = 0.70 (0.55-0.90), P = .005) 
and those living in states with TGGD inclusions in Medicaid policies were more likely to use 
therapy/counseling (aOR and 95% CI = 1.26 (1.06-1.49), P = .009). Living in a state with 
nondiscrimination protections for TGGD people was associated with increased use of hormone 
treatment (aOR and 95% CI = 1.21 (1.02-1.43), P = .029). 
Across all models, none of the state-level covariates were significantly associated with either 
counseling/therapy or hormone treatment, but most of the individual-level covariates were 
significant. For both outcomes, the random intercept was significant. This means that there was 
unobserved heterogeneity; even after controlling for all of the individual- and state-level variables in 
the model, the likelihood of accessing therapy/counseling or hormone treatment still varied by state. 
For both outcomes, the random slope of race/ethnicity was also significant. Thus, after controlling 
for all other factors in the model, the relationship between race/ethnicity and the use of medical 
gender affirmation services varied across U.S. states.  
Figures 5 and 6 include descriptive data highlighting racial/ethnic differences in the use of 
medical gender affirmation services across states. As shown in Figure 5, in nearly all states, TGGD 
people of color reported less use of therapy/counseling than non-Hispanic white participants. 
However, the difference in use varied across states, with some states (eg, Kansas, New Hampshire, 
and Nebraska) having large racial/ethnic disparities in use of therapy/counseling and other states 
(eg, Ohio, Idaho, and Connecticut) having similar percentages of therapy/counseling use across 
groups. In six states (eg, Tennessee, Maine, and Indiana), more TGGD people of color than non-
Hispanic white participants reported use of therapy/counseling. Figure 5 excludes 10 states that had 
fewer than 10 participants of color who reported wanting therapy/counseling. 
As shown in Figure 6, TGGD people of color in most states reported lower use of hormone 
treatment than non-Hispanic white participants. Iowa, Florida, and Alabama demonstrated the 
biggest differences in race/ethnicity, with non-Hispanic white participants having more use of 
hormone treatment. A few states, including Pennsylvania, the District of Columbia, and Connecticut, 
had similar results across racial/ethnic groups. Finally, as with therapy/counseling, some states (eg, 
Idaho, Tennessee, Kentucky, and Hawaii) had more TGGD people of color reporting use of hormone 
treatment than non-Hispanic white participants. Data from seven states are not presented because 












To our knowledge, this is the first study to explore the relationship between state-level TGGD-
specific policies and the use of medical gender affirmation services. Policies related to discrimination 
were associated with both outcomes: broad religious exemption laws were associated with less use 
of therapy/counseling, and the inclusion of gender identity/expression in nondiscrimination 
protections was associated with greater hormone treatment use. Discrimination-related policies may 
reflect the experiences of enacted and anticipated stigma occurring within each state. Previous 
research found that stigma (and especially stigma within health care settings) was a barrier for 
accessing medical gender affirmation services.2,17 These policies prohibit and/or allow for 
discrimination to occur across a range of settings, including within health care settings. Therefore, it 
is possible that individuals living in states with more protective nondiscrimination policies and those 
living in states without stigmatizing religious exemption laws are less likely to anticipate stigma 
within health care settings, and more able to access medical gender affirmation services when they 
want them. 
Medicaid policies were only significantly associated with the use of therapy/counseling, with 
TGGD Medicaid inclusions being associated with increased use of therapy/counseling and TGGD 
Medicaid exclusions being associated with decreased use of therapy/counseling. Cost can be a huge 
barrier for accessing health care, especially therapy/counseling.5,28,29 The finding that Medicaid 
policies were significantly associated with use of therapy/counseling, and private health insurance 
policies were not, may indicate that  health insurance coverage for therapy/counseling visits is 
especially important for participants using Medicaid.  
In contrast, Medicaid policies were not significantly associated with hormone treatment use. 
Therapy/counseling and hormone treatment are very different types of services, offered by different 
types of providers, and that may account for differences in findings for the two outcomes. More 
research examining the relationships between health insurance, Medicaid policies, and medical 
gender affirmation services is warranted. 
The composite policy index demonstrated that having more protective and fewer 
stigmatizing policies was significantly associated with increased use of both therapy/counseling and 
hormone treatment. This finding highlights that the overall sociopolitical climate matters for medical 
gender affirmation service use and, since only a few individual policies were significantly associated 
with medical gender affirmation services, the sociopolitical climate may be more important for 
medical gender affirmation service use than individual policies. Future exploration of state policies 
and aspects of the sociopolitical context not included in this analysis (eg, adoption/parenting laws, 
safe school laws, bathroom bills, conversion therapy laws) may bring additional insights into the 
importance of specific policies relative to the overall sociopolitical context.  
It is important to note that individual policies are always reciprocally related to the 
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stigmatizing policy if they live in a state with a more stigmatizing environment; that stigmatizing 
policy also contributes to the sociopolitical context and may make it easier to pass more stigmatizing 
policies in the future. Stigmatizing processes occur within iterative social contexts and across 
multiple socioecological levels.30 Individuals and institutions function within cultural ideologies that 
are embedded in society, and yet these cultural ideologies are generated by individuals and 
institutions. 
The significant random intercept indicates that, even after controlling for all of the 
covariates, experiences with medical gender affirmation services varied across states. This analysis 
may not have included additional state-level factors that account for this variation. For example, this 
study did not include measures of the availability of medical gender affirmation services or other 
social factors (eg, experiences in schools, with bathrooms) that may account for transgender-related 
stigma in the social environment; these unmeasured variables may play a role in the use of medical 
gender affirmation services and may account for differences across states. 
The random slope was also significant, indicating that the relationship between 
race/ethnicity and use of medical gender affirmation services varied across states and is probably 
context specific. The descriptive statistics highlighted that, across most states, TGGD people of color 
reported less use of medical gender affirmation services than their non-Hispanic white counterparts, 
with the severity of this inequity varying from state to state. In some states, the percentage of TGGD 
people of color reporting use of medical gender affirmation services exceeded the percentage of 
non-Hispanic white participants using them. The reasons for these differences are not entirely clear; 
however, some of the differences may be due to the differences in the breakdown of the 
racial/ethnic minority groups across states. For example, Hawaii (which had more participants of 
color than white participants reporting hormone treatment use) had a large sample of Asian, Native 
Hawaiian, and Pacific Islander participants (31%) and 45% of participants in that state identified as 
non-Hispanic white. In contrast, Florida (which had more non-Hispanic white participants than 
participants of color reporting hormone treatment use) had a larger sample of non-Hispanic white 
participants (75%), with Latinx/Hispanic participants comprising the largest group among 
racial/ethnic minority participants in this state (10%).  
In addition, even though this study controlled for an individual’s race/ethnicity, experiences 
of racism, and a state’s racial makeup, other factors related to race/ethnicity (eg, the frequency and 
severity of transgender-related and racist stigma) may account for differences in associations 
between race/ethnicity and health care use across states. Given that different US states and regions 
have varied social and historical contexts, especially regarding experiences of race/ethnicity and 
racism,31 it makes sense that the relationship between race/ethnicity and the use of the medical 











Our findings highlight the importance of advocating for state-level policies that provide 
protections to TGGD populations and against those that further perpetuate transgender-related 
stigma. If we aim to achieve health equity for TGGD people, it is necessary to consider how policies 
may shape access to health care, and ultimately affect health outcomes. Pervasive transgender-
related stigma contributes to poor access to care and poor health outcomes,17 but the passing of 
more protective policies may help to foster resilience and reduce experiences of stigma, ultimately 
improving the health of TGGD populations. 
When considering state-level TGGD-specific policies, it is also important to consider the role 
of race/ethnicity. The relationship between race/ethnicity and the use of medical gender affirmation 
services varied across states, indicating that the state-level social environment may play a role in the 
relationship between race/ethnicity and use of care. It is important to consider how the 
implementation of TGGD-specific policies may shape experiences for different TGGD groups in 
different ways. When implementing policies, the effects on the lives of the most marginalized and 
stigmatized populations (ie, those who experience multiple and intersecting forms of stigma, such as 
TGGD people of color) should be considered. If we fail to achieve an intersectional understanding of 




Further research is needed to better understand the nuanced relationships between federal, state, 
and local TGGD-specific policies and access to medical gender affirmation services among TGGD 
people. Individual policies and composite policy indices can be useful for understanding both 
individual policies and the larger social context. While the USTS provides rich data for exploring 
state-level policies and differences in experiences of TGGD people across states, longitudinal studies 
would allow for causal inferences and a deeper understanding of the effects of policies and policy 
changes over time. As more longitudinal studies (eg, BRFSS) begin collecting data on experiences of 
gender identity, further analyses exploring the effects of these policies over time will be possible. As 
these data are collected, it is important to apply an intersectionality approach11 and further explore 
experiences of other types of stigma (eg, stigma related to disability status, sexual identity, 
socioeconomic status, body size, HIV status, and immigration status), so that the needs of TGGD 











There were some limitations to this research. Data are cross sectional, so no causal inferences can 
be made. The study also used a convenience sample that was almost entirely collected online; these 
sampling methods and procedures are common among hard-to-reach populations,32 but caution 
should be taken when generalizing results. The sample was disproportionately non-Hispanic white 
when compared with the US population as a whole; this is especially notable because estimates 
suggest that TGGD populations are more racially and ethnically diverse than the general US 
population.33 The relatively small sample of people of color required the use of a binary variable 
when exploring race/ethnicity across states because there were too few participants of color in each 
state to include more nuanced variables. The lack of racial/ethnic diversity also limited the health 
care use outcomes that could be used in this analysis. Specifically, there were too few people of 
color in each state who had accessed medical gender affirmation surgery for us to explore 
associations between race/ethnicity and surgery across states. 
Although this analysis accounted for the timing of policies and the USTS data collection, 
policies related to identity documents were based on more recent data than the survey data. 
Furthermore, it is possible that policies that did not exist in 2015 were being discussed at the time, 
potentially affecting the sociopolitical climate. Analysis was also limited to variables available in the 
USTS; additional measures on quality of services or use of therapy/counseling for other reasons 
could further elucidate the findings. Finally, even though this study explored state-level differences, 
this analysis was unable to consider migration patterns and length of state residency; migration 
patterns among TGGD people are not random and could influence experiences of medical gender 




Overall, this study suggests that state-level TGGD-specific policies are important for access 
to and use of medical gender affirmation services for TGGD people across the United States. This 
study also explores how race/ethnicity may relate to the use of medical gender affirmation services 
across US states. Within a stigmatizing US political climate, where policies specific to the experiences 
of TGGD people are increasing,6 it is important to advocate for protective policies and advocate 
against harmful ones, in order to improve the health of TGGD people. Improving TGGD-specific 
policies may help increase access to needed health care services and, as a result, may ultimately help 
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Figure 2. Distribution of Transgender-Specific Health Insurance Policies 
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Figure 4. Composite Policy Index 
 
 
To create the composite policy index, each state received a +1 for each protective policy that it had, 
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Figure 5. Comparisons of Use of Therapy/Counseling by Race/Ethnicity Across US States 
  
Figure excludes all states with fewer than 10 transgender and other gender-diverse (TGGD) 
participants of color who reported wanting therapy/counseling: Alaska, Delaware, Iowa, Mississippi, 
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Figure excludes all states with fewer than 10 transgender and other gender-diverse (TGGD) 
participants of color who reported wanting hormone treatment: Alaska, Mississippi, Montana, North 
Dakota, South Dakota, West Virginia, and Wyoming. 








(N = 18,421) 
State-level policies   
Nondiscrimination protections, % (n)   
State policy includes gender identity/expression 47.81 (8,699) 47.71 (8,788) 
State policy does not include gender identity/expression 52.19 (9,496) 52.29 (9,633) 
Religious exemption laws, % (n)   
Broad law exists in state 35.61 (6,480) 36.04 (6,639) 
Only specific law exists in state 6.97 (1,269) 7.06 (1,300) 
No law exists in state 57.41 (10,446) 56.90 (10,482) 
Private health insurance, % (n)   
State policy has TGGD-specific protections 39.13 (7,119) 39.14 (7,210) 
State policy does not have TGGD-specific protections 60.87 (11,076) 60.86 (11,211) 
Medicaid policies, % (n)   
State has TGGD-specific Medicaid policies 71.31 (12,975) 71.43 (13,158) 
State excludes TGGD-specific care 5.57 (1,014) 5.53 (1,018) 
State includes TGGD-specific care 23.12 (4,206) 23.04 (4,245) 
Gender marker change requirements on state ID, % (n)   
No policies exist in state 1.45 (264) 1.49 (274) 
State requires proof of surgery, court order, or amended birth 
certificate 
19.07 (3,469) 19.18 (3,534) 
State accepts documentation from a limited list of providers 37.93 (6,902) 37.71 (6,946) 
State accepts documentation from a broad range of providers 41.55 (7,560) 41.62 (7,667) 
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State has unclear rules or requirements are decided by an 
individual court 
48.97 (8,911) 49.09 (9,043) 
State requires a public announcement 8.44 (1,536) 8.21 (1,512) 
State does not require a public announcement 42.58 (7,748) 42.70 (7,866) 
Composite score, mean (SD) 1.61 (2.15) 1.61 (2.15) 
State-level characteristics   
State proportion of non-Hispanic white people, mean (SD) 77.81 (8.59) 77.83 (8.63) 
State population density, mean (SD) 318.36 (872.72) 315.44 (864.55) 
State proportion living in an urban area, mean (SD) 0.56 (0.22) 0.56 (0.22) 
Individual-level sociodemographic characteristics   
Age (y), mean (SD) 31.03 (12.84) 31.45 (12.97) 
Gender identity, % (n)   
Transfeminine 37.47 (6,817) 41.25 (7,599) 
Transmasculine 30.70 (5,586) 36.11 (6,651) 
Other gender diverse (AFAB) 25.45 (4,631) 17.46 (3,217) 
Other gender diverse (AMAB) 6.38 (1,161) 5.18 (954) 
Sexual identity, % (n)   
Heterosexual/straight 11.01 (2,004) 12.75 (2,349) 
LGB+ 73.17 (13,313) 71.85 (13,236) 
Asexual 9.40 (1,711) 9.11 (1,679) 
Other 6.41 (1,167) 6.28 (1,157) 
Race/ethnicity, % (n)   
Non-Hispanic White 81.62 (14,851) 81.48 (15,010) 
American Indian/Alaska Native 1.13 (205) 1.19 (220) 
Asian, Native Hawaiian, Pacific Islander 2.59 (472) 2.68 (493) 
Black 2.53 (461) 2.71 (500) 
Latinx/Hispanic 5.03 (916) 4.90 (902) 
Multiracial 4.48 (816) 4.46 (822) 
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Has U.S. citizenship, % (n) 98.40 (17,903) 98.41 (18,128) 
Highest education level, % (n)   
Less than high school 2.73 (496) 2.92 (537) 
High school graduate (including GED) 11.12 (2,023) 11.76 (2,166) 
Some college (no degree) 37.71 (6,862) 37.50 (6,908) 
Undergraduate degree 34.93 (6,355) 34.53 (6,361) 
Graduate or professional degree 13.51 (2,459) 13.29 (2,449) 
Employment status, % (n)   
Employed 67.45 (12,272) 67.42 (12,420) 
Unemployed 12.72 (2,314) 12.69 (2,338) 
Out of the labor force 19.84 (3,609) 19.88 (3,663) 
Experiences of transgender-related stigma in past year   
Experienced discrimination, % (n) 14.75 (2,683) 15.26 (2,811) 
Experienced verbal harassment, % (n) 49.13 (8,940) 47.81 (8,807) 
Experienced physical violence, % (n) 9.19 (1,672) 9.00 (1,658) 
Experiences of racism in past year   
Experienced discrimination, % (n) 1.79 (326) 1.70 (313) 
Experienced verbal harassment, % (n) 4.83 (878) 4.40 (810) 
Experienced physical violence, % (n) 0.89 (162) 0.76 (140) 
Gender expression, outness, and social support 
Living full time in gender different from sex assigned at birth, % (n) 62.80 (11,426) 68.20 (12,564) 
Outness scale, mean (SD) 3.61 (2.34) 3.90 (2.27) 
Has social support, % (n) 63.49 (11,552) 66.67 (12,281) 
Systemic vulnerability   
Living at/near poverty, % (n) 32.67 (5,945) 32.34 (5,958) 
Ever experienced homelessness, % (n) 29.83 (5,427) 30.88 (5,689) 
Incarcerated in the past year, % (n) 1.27 (231) 1.38 (254) 
Ever engaged in sex work/industry, % (n) 10.16 (1,849) 10.94 (2,016) 
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Experienced psychological distress in the past month, % (n) 40.44 (7,358) 38.29 (7,054) 
Ever experienced suicidal ideation, % (n) 84.46 (15,368) 83.81 (15,439) 
HIV status, % (n)   
Not living with HIV 52.67 (9,583) 53.50 (9,855) 
Living with HIV 0.55 (100) 0.69 (128) 
Never tested/does not know 46.78 (8,512) 45.81 (8,438) 
Experienced binge drinking in the past 30 days, % (n) 25.71 (4,678) 25.39 (4,678) 
Used drugs in the past 30 days, % (n) 28.63 (5,209) 28.66 (5,280) 
Has health insurance coverage, % (n) 87.99 (16,009) 87.56 (16,130) 
Abbreviations: AFAB, assigned female at birth; AMAB, assigned male at birth; GED, general educational 
development certificate; HRT, hormone replacement treatment; LGB+, lesbian, gay, bisexual, etc.; SD, 
standard deviation; TGGD, transgender and other gender-diverse. 
 
Table 2. Sample Distributions and Bivariate Analyses Examining the Use of Therapy/Counseling 









State-level policies   
Nondiscrimination protections   
State policy includes gender identity/expression 69.80 (6,072) 66.02 (5,802) 
State policy does not include gender identity/expression 65.06 (6,178) 57.15 (5,505) 
Religious exemption laws   
Broad law exists in state 64.03 (4,149) 56.54 (3,754) 
Only specific law exists in state 64.38 (817) 55.62 (723) 
No law exists in state 69.73 (7,284) 65.16 (6,830) 
Private health insurance   
State policy has TGGD-specific protections 70.70 (5,033) 67.02 (4,832) 
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Medicaid policies   
State has TGGD-specific Medicaid policies 66.09 (8,575) 59.37 (7,812) 
State excludes TGGD-specific care 63.91 (648) 58.84 (599) 
State includes TGGD-specific care 71.97 (3,027) 68.22 (2,896) 
Gender marker change requirements on state ID   
No policies exist in state 63.26 (167) 50.73 (139) 
State requires proof of surgery, court order, or amended birth 
certificate 
62.78 (2,178) 55.43 (1,959) 
State accepts documentation from a limited list of providers 66.85 (4,614) 60.03 (4,170) 
State accepts documentation from a broad range of providers 69.99 (5,291) 65.72 (5,039) 
Legal name change requirements   
State has unclear rules or requirements are decided by an individual 
court 
67.82 (6,043) 61.38 (5,551) 
State requires a public announcement 63.22 (971) 56.15 (849) 
State does not require a public announcement 67.58 (5,236) 62.38 (4,907) 
Composite score, mean (SD) 1.71 (2.14) 1.77 (2.16) 
State-level characteristics   
State proportion of non-Hispanic white people, mean (SD) 77.84 (8.63) 77.63 (8.79) 
State population density, mean (SD) 327.95 (909.44) 338.59 
(972.34) 
State proportion living in an urban area, mean (SD) 0.56 (0.22) 0.57 (0.22) 
Individual-level sociodemographic characteristics   
Age (y), mean (SD) 33.77 (13.51) 34.81 (13.41) 
Gender identity   
Transfeminine 82.37 (5,615) 74.92 (5,693) 
Transmasculine 76.28 (4,261) 67.88 (4,515) 
Other gender diverse (AFAB) 39.00 (1,806) 24.65 (793) 
Other gender diverse (AMAB) 48.92 (568) 32.08 (306) 
Sexual identity   
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LGB+ 68.14 (9,072) 61.89 (8,192) 
Asexual 48.51 (830) 41.81 (702) 
Other 58.01 (677) 49.78 (576) 
Race/ethnicity   
Non-Hispanic white 68.75 (10,210) 61.92 (9,294) 
American Indian/Alaska Native 62.44 (128) 58.64 (129) 
Asian, Native Hawaiian, Pacific Islander 61.86 (292) 55.78 (275) 
Black 64.64 (298) 65.80 (329) 
Latinx/Hispanic 57.97 (531) 56.43 (509) 
Multiracial 57.97 (473) 57.06 (469) 
Other 67.09 (318) 63.71 (302) 
Has U.S. citizenship   
Yes 67.44 (12,037) 61.45 (11,139) 
No 60.62 (177) 57.34 (168) 
Highest education level   
Less than high school 42.94 (213) 34.26 (184) 
High school graduate (including GED) 51.71 (1,046) 42.47 (920) 
Some college (no degree) 59.87 (4,108) 53.58 (3,701) 
Undergraduate degree 75.12 (4,774) 70.49 (4,484) 
Graduate or professional degree 85.77 (2,109) 82.40 (2,018) 
Employment status   
Employed 71.25 (8,744) 65.75 (8,166) 
Unemployed 52.59 (1,217) 44.87 (1,049) 
Out of the labor force 63.42 (2,289) 57.11 (2,092) 
Experiences of transgender-related stigma in past year   
Experienced discrimination   
Yes 73.20 (1,964) 71.33 (2,005) 
No 66.31 (10,286) 59.59 (9,302) 
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Yes 65.18 (5,827) 59.33 (5,225) 
No 69.40 (6,423) 63.26 (6,082) 
Experienced physical violence   
Yes 61.96 (1,036) 59.11 (980) 
No 67.87 (11,214) 61.61 (10,327) 
Experiences of racism in past year   
Experienced discrimination   
Yes 57.67 (188) 58.15 (182) 
No 67.50 (12,062) 61.44 (11,125) 
Experienced verbal harassment   
Yes 55.81 (490) 53.58 (434) 
No 67.91 (11,760) 61.74 (10,873) 
Experienced physical violence   
Yes 51.85 (84) 56.14 (80) 
No 67.47 (12,166) 61.41 (11,227) 
Gender expression, outness, and social support   
Living full time in gender different from sex assigned at birth   
Yes 79.89 (9,128) 78.44 (9,855) 
No 46.12 (3,122) 24.79 (1,452) 
Outness scale, mean (SD) 4.35 (2.16) 4.85 (1.91) 
Has social support   
Yes 76.80 (8,872) 70.61 (8,672) 
No 50.85 (3,378) 42.92 (2,635) 
Systemic vulnerability   
Living at/near poverty   
Yes 57.86 (3,440) 51.76 (3,084) 
No 71.92 (8,810) 65.98 (8,223) 
Ever experienced homelessness   
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No 66.90 (8,542) 58.94 (7,504) 
Incarcerated in the past year   
Yes 69.26 (160) 63.78 (162) 
No 67.30 (12,090) 61.35 (11,145) 
Ever engaged in sex work/industry   
Yes 70.25 (1,299) 72.72 (1,466) 
No 66.99 (10,951) 59.99 (9,841) 
Health status and health insurance   
Experienced psychological distress in the past month   
Yes 55.25 (4,065) 46.27 (3,264) 
No 75.53 (8,185) 70.76 (8,043) 
Ever experienced suicidal ideation   
Yes 66.53 (10,224) 60.70 (9,371) 
No 71.67 (2,026) 64.92 (1,936) 
HIV status   
Not living with HIV 77.85 (7,460) 75.97 (7,487) 
Living with HIV 73.00 (73) 82.81 (106) 
Never tested/does not know 55.42 (4,717) 44.02 (3,714) 
Experienced binge drinking in the past 30 days   
Yes 67.89 (3,176) 63.83 (2,986) 
No 67.13 (9,074) 60.55 (8,321) 
Used drugs in the past 30 days   
Yes 68.77 (3,582) 66.23 (3,497) 
No 66.75 (8,668) 59.43 (7,810) 
Has health insurance coverage   
Yes 69.30 (11,094) 62.79 (10,128) 
No 52.88 (1,156) 51.46 (1,179) 
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Abbreviations: AFAB, assigned female at birth; AMAB, assigned male at birth; GED, general educational 
development certificate; HRT, hormone replacement treatment; LGB+, lesbian, gay, bisexual, etc.; SD, 
standard deviation; TGGD, transgender and other gender-diverse. 
aBold text indicates that bivariate analyses were statistically significant (P <0.05). 
 
Table 3. Multilevel, Multivariable Logistic Regression Results Examining the Relationships between Individual 
Policies and Medical Gender Affirmation Services 
 Therapy/Counseling 
 (n = 18,195) 
Hormone 
Treatment 
(n = 18,421) 
 aOR 95% CI aOR 95% CI 
State-Level Policies     
Nondiscrimination protections     
State policy includes gender identity/expression 0.89 0.78-1.02 1.21
a
 1.02-1.43 
State policy does not include gender identity/expression Reference Group Reference Group 
Religious exemption laws     
Broad law exists in state 0.84
a
 0.74-0.96 0.93 0.79-1.09 
Only specific law exists in state 0.92 0.75-1.12 1.12 0.87-1.46 
No law exists in state Reference Group Reference Group 
Private health insurance policies     
State policy has TGGD-specific protections 1.06 0.93-1.21 1.15 0.96-1.36 
State policy does not have TGGD-specific protections Reference Group Reference Group 
Medicaid policies     
State has no TGGD-specific Medicaid policies Reference Group Reference Group 
State excludes TGGD-specific care 0.70
b
 0.55-0.90 0.90 0.67-1.20 
State includes TGGD-specific care 1.26
b
 1.06-1.49 0.97 0.77-1.23 
Gender marker change requirements on state ID     
No policies exist in state Reference Group Reference Group 
State requires proof of surgery, court order, or amended birth 
certificate 
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State accepts documentation from a limited list of providers 1.20 0.82-1.74 1.13 0.74-1.73 
State accepts documentation from a broad range of providers 1.14 0.78-1.67 1.30 0.84-2.00 
Legal name change requirements     
State has unclear rules or requirements are decided by an individual 
court 
Reference Group Reference Group 
State requires a public announcement 1.03 0.86-1.23 0.90 0.72-1.11 
State does not require a public announcement 0.97 0.87-1.09 0.90 0.77-1.04 
State-Level Characteristics     
State proportion of non-Hispanic white people 1.00 1.00-1.00 1.00 0.99-1.00 
State population density  1.00 1.00-1.00 1.00 1.00-1.00 
State proportion living in an urban area 0.88 0.67-1.16 1.06 0.77-1.47 






Gender identity     
















Sexual identity     














Race/ethnicity     
Non-Hispanic white Reference Group Reference Group 
American Indian/Alaska Native 0.61
b
 0.43-0.87 0.69 0.47-1.00 
Asian, Native Hawaiian, Pacific Islander 0.99 0.77-1.26 1.06 0.80-1.39 
Black 0.93 0.72-1.20 1.04 0.78-1.37 
Latinx/Hispanic 0.76
b









 0.68-0.98 1.07 0.87-1.31 
Other 0.98 0.76-1.26 1.07 0.81-1.40 





Highest education level     
Less than high school Reference Group Reference Group 
High school graduate (including GED) 1.16 0.91-1.47 1.18 0.91-1.54 















Employment status     






Out of the labor force 1.10 1.00-1.22 1.08 0.96-1.21 
Experiences of Transgender-Related Stigma in Past Year     
Experienced discrimination 1.03 0.91-1.17 1.34
c
 1.17-1.53 





Experienced physical violence 0.91 0.79-1.05 0.81
a
 0.69-0.95 
Experiences of Racism in Past Year     
Experienced discrimination 0.92 0.66-1.27 0.86 0.59-1.25 
Experienced verbal harassment 0.98 0.80-1.21 0.94 0.74-1.19 
Experienced physical violence 0.89 0.58-1.36 1.27 0.75-2.14 
Gender Expression, Outness, and Social Support     















Systemic Vulnerability     
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Ever engaged in sex work/industry 0.94 0.82-1.08 1.27
b
 1.09-1.48 
Health Status and Health Insurance     










HIV status     
Not living with HIV Reference Group Reference Group 
Living with HIV 0.44
b
 0.26-0.76 0.67 0.37,1.20 





Experienced binge drinking in the past 30 days 0.98 0.89-1.08 1.04 0.84-1.15 
Used drugs in the past 30 days 1.04 0.95-1.14 1.20
c
 1.09-1.33 





Abbreviations: AFAB, assigned female at birth; AMAB, assigned male at birth; aOR, adjusted odds ratio; CI, 
confidence interval; GED, general educational development certificate; HRT, hormone replacement treatment; 
LGB+, lesbian, gay, bisexual, etc.; TGGD, transgender and other gender-diverse. 
a
P <.05 
b
P <.01 
c
P <.001 
 
 
